Reduced placental growth and hCG secretion in vitro induced by antiphospholipid antibodies but not by anti-Ro or anti-La: Studies on sera from women with SLE/PAPS

Lupus

Volumn 16, Issue 2, 2007, Pages 110-120

  Schwartz, N ^a   Shoenfeld, Y ^b   Barzilai, O ^b   Cervera, R ^c   Font, J ^c   Blank, M ^b   Yacobi, S ^a   Patlas, N ^a   Cohen, A ^a   Mevorach, D ^a   Ornoy, Asher ^a  

^a HEBREW UNIVERSITY   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

hCG; Anti phospholipid antibodies (aPL); Anti Ro and anti La; Pregnancy loss; Systemic lupus erythematosus primary anti phospholipid syndrome (SLE PAPS)

Indexed keywords

CARDIOLIPIN ANTIBODY; CHORIONIC GONADOTROPIN; ESTRADIOL; LA ANTIBODY; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROGESTERONE; RO ANTIBODY;

ABORTION; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HORMONE ACTION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM; TROPHOBLAST;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIGENS; CHORIONIC GONADOTROPIN; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PLACENTA; RIBONUCLEOPROTEINS;

EID: 33847342024     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306075741     Document Type: Article

References (36)

1. Ornoy A, Chen L, Silver RM, Miller RK. Maternal autoimmune diseases and immunologically induced embryonic and fetoplacental damage. Birth Defects Res A Clin Mol Teratol 2004; 70: 371-381.
2. Schur PH, Bermas BL. Pregnancy in women with systemic lupus erythematosus. Available from www.uptodate.com, 2005.
3. George NT. APA and the antiphospholipid antibody syndrome. Am J Dermatology 1997; 36: 149-163.
4. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.
5. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT. Decidual vasculopathy of the placenta in systemic lupus erythematosus. N Engl J Med 1980; 303: 668-672.
6. Katsuragawa H, Rote NS, Inoue T, Narukawa S, Kanzaki H, Mori T. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172: 1592-1597.
7. Abir R, Ornoy A. Teratogenic IgG from sera of women with spontaneous abortions seem to induce anomalies and yolk sac damage in rat embryos. A possible method to detect abortions of immunologic origin. Am J Reprod Immun 1996; 35: 93-101.
8. Ornoy A, Yacobi S, Avraham S, Blumenfeld Z. The effect of sera from women with systemic lupus erythematosus and/or antiphospholipid syndrome on rat embryos in culture. Reprod Toxicol 1998; 12: 185-191.
9. Yacobi S, Ornoy A, Blumenfeld Z, Miller RK. Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002; 66: 300-308.
10. Genbacev O, Miller RK. Three-dimensional culture of placental villous tissue explants: an in vitro model for periimplantation. Methods in Toxicology 1993; 3B: 246-265.
11. Genbacev O, Miller RK. Post-implantation differentiation and proliferation of cytotrophoblast cells: in vitro models - a review. Placenta 2000; 21(Suppl. A): S45-S49.
12. To CH, Petri M. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus? Arthritis Rheum 2005; 52: 4003-4010.
13. Bermas BL, Schur PH. Pathogenesis of the antiphospholipid syndrome. Available from www.uptodate.com, 2005.
14. Sailer T, Zoghlami C, Kurz C et al. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant. Thromb Haemost 2006; 95: 796-801.
15. Blank M, Cohen J, Toder V, Shoenfeld Y. Induction of anti-phospholipid syndrome by passive transfer of anti-cardiolipin antibodies. Proc Nat Acad Sci 1991; 88: 3069-3073.
16. George J, Blank M, Levy Y et al. Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome. Circulation 1998; 97: 900-906.
17. Blank M, Shoenfeld Y, Cabilly S, Heldman Y, Fridkin M, Katchalski-Katzir E. Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc Narl Acad Sci (USA) 1999; 96: 5164-5168.
18. Ieko M, Nakabayashi T, Tarumi T et al. Phosphatidylserine- dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome. Rinsho Byori 2006; 54: 256-262.
19. Lopez LR, Dier KJ, Lopez D, Merrill JT, Fink CA. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. Am J Clin Pathol 2004; 121: 142-149.
20. Toschi V, Motta A, Castelli C et al. Prevalence and clinical significance of aPL to noncardiolipin antigens in systemic lupus erythematosus. Haemostasis 1993; 23: 275-283.
21. Balada E, Ordi-Ros J, Paredes F, Villarreal J, Mauri M, Vilardell-Tarres M. Antiphosphatidylethanolamine antibodies contribute to the diagnosis of antiphospholipid syndrome in patients with systemic lupus erythematosus. Scand J Rheumatol 2001; 30: 235-241.
22. Karmochkine M, Berard M, Piette JC et al. Antiphosphatidylethanolamine antibodies in systemic lupus erythematosus. Lupus 1993; 2: 157-160.
23. Reichlin M. Clinical significance of anti-Ro/SSA and anti-La/SSB antibodies. Available from www.uptodate.com, 2005.
24. Watson RM, Braunstein BL, Watson AJ, Hochberg MC, Provost TT. Fetal wastage in women with anti-Ro/SSa antibody. The Journal of Rheumatology 1986; 13: 90-94.
25. Mavragani CP, Dafni UG, Tzioufas AG, Moutsopoulos HM. Pregnancy outcome and anti-Ro/SSA in autoimmune diseases: a retrospective cohort study. British J Rheumatol 1998; 37: 740-745.
26. Brucato A, Doria A, Frassi M et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716-721.
27. Blank M, Faden D, Tincani A et al. Immunization with anticardiolipin cofactor (beta-2-glycoprotein I) induces experimental antiphospholipid syndrome in naive mice. J Autoimmun 1994; 7: 441-455.
28. Qureshi F, Yang Y, Jaques SM et al. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. Am J Reprod Immunol 2000; 44: 136-142.
29. Sakui H, Yoshimura Y, Tada S et al. Serological and immunohistochemical studies in pregnant women with systemic lupus erythematosus. Nippon Sanka Fujinka Gakkai Zasshi 1989; 41: 249-256.
30. Salmon JE, Girardi G, Holers VM. Activation of complement mediates antiphospholipid antibody-induced pregnancy loss. Lupus 2003; 12: 535-538.
31. Hanly JG, Gladman DD, Rose TH, Laskin CA, Urowitz MB. Lupus pregnancy. A prospective study of placental changes. Arthritis rheum 1988; 31: 358-366.
32. Rull K, Laan M. Expression of beta-subunit of HCG genes during normal and failed pregnancy. Hum Reprod 2005; 20: 3360-3368.
33. Bahado-Singh RO, Oz AU, Kingston JM, Shahabi S, Hsu CD, Cole L. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn 2002; 22: 478-481.
34. Shi QJ, Lei ZM, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology 1993; 132: 1387-1395.
35. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS. Monoclonal antibody against antiphosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997; 56: 5650-5658.
36. Shurtz-Swirski R, Inbar O, Blank M, Cohen J, Bakimer R, Shoenfeld Y. In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy. Amer J Reproduc Immunol 1993; 29: 206-210.